Passa al contenuto
Merck

Heme oxygenase-1 attenuates inflammation and oxidative damage in a rat model of smoke-induced emphysema.

International journal of molecular medicine (2015-09-24)
Jingjing Wei, Guoquan Fan, Hui Zhao, Jianqiang Li
ABSTRACT

Emphysema is a serious disease of the respiratory system and is associated with inflammation and oxidative stress. Heme oxygenase-1 (HO-1), a rate-limiting enzyme involved in heme biosynthesis, exerts potent anti-inflammatory, antioxidant, anti-apoptotic and anti‑proliferative effects in various diseases. In the present study, we examined the effects of HO-1 on smoke‑induced emphysema, as well as the underlying mechanisms in a rat model of smoke-induced emphysema. Rats were either exposed to cigarette smoke or sham‑exposed for 20 weeks to establish the model of smoke-induced emphysema. The rats were subcutaneously injected with protoporphyrin IX [tin-protoporphyrin IX (SnPP) or ferriprotoporphyrin IX chloride (hemin)] during this period to examine the protective effects of HO-1. Subsequently, the development of emphysema, inflammatory cells, the levels of inflammatory mediators, particularly interleukin (IL)-17, tumor necrosis factor (TNF)‑α, monocyte chemotactic protein‑1 [MCP‑1, also known as chemokine (C-C motif) ligand 2 (CCL2)], IL-8 [also known as chemokine (C-X-C motif) ligand 8 (CXCL8)], macrophage inflammatory protein‑2α [MIP-2α, also known as chemokine (C-X-C motif) ligand 2 (CXCL2)] and IL-10, as well as the malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione (GSH) content were determined. Exposure to smoke increased the total cell, neutrophil and macrophage counts in the bronchoalveolar lavage fluid (BALF). It also increased the levels of the inflammatory mediators, IL-17, TNF-α, MCP-1, IL-8 and MIP-2α, as well as the MDA content and induced emphysema. Treatment with hemin upregulated HO-1 expression and attenuated the development of smoke-induced emphysema by reducing inflammatory cell infiltration, decreasing the levels of inflammatory mediators and attenuating oxidative damage, to a certain extent. In conclusion, our findings demonstrate that HO-1 exerts anti-inflammatory and antioxidant effects, thus attenuating the development of smoke-induced emphysema.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Metanolo, ACS reagent, ≥99.8%
Sigma-Aldrich
Formaldeide, Molecular Biology, 36.5-38% in H2O
Sigma-Aldrich
Formaldeide, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
SAFC
Formaldeide, contains 10-15% methanol as stabilizer, 37 wt. % in H2O
Sigma-Aldrich
Metanolo, Laboratory Reagent, ≥99.6%
Sigma-Aldrich
Metanolo, ACS spectrophotometric grade, ≥99.9%
Sigma-Aldrich
Metanolo, ACS reagent, ≥99.8%
Sigma-Aldrich
Methylene blue, certified by the BSC
Sigma-Aldrich
Metanolo, Absolute - Acetone free
Sigma-Aldrich
Formaldeide, Molecular Biology, BioReagent, ≥36.0% in H2O (T)
Sigma-Aldrich
Methylene Blue solution, concentrate according to Ehrlich, concentrated, aqueous solution
Sigma-Aldrich
2-Thiobarbituric acid, ≥98%
Sigma-Aldrich
Metanolo, BioReagent, ≥99.93%
Sigma-Aldrich
Ematossilina
Sigma-Aldrich
Eosin Y solution, 5 wt. % in H2O
Sigma-Aldrich
Formaldeide, meets analytical specification of USP, ≥34.5 wt. %
Sigma-Aldrich
Eosin Y, Dye content ~99 %
Sigma-Aldrich
Metanolo, ACS reagent, ≥99.8%
Sigma-Aldrich
Ematossilina, certified by the BSC
Supelco
Formaldeide, stabilized with methanol, ~37 wt. % in H2O, certified reference material
Sigma-Aldrich
Eosin Y disodium salt, certified by the BSC
Sigma-Aldrich
Eosin Y disodium salt, ≥85 % by HPLC
Sigma-Aldrich
Methylene Blue solution, 0.05 wt. % in H2O
Sigma-Aldrich
Eosin Y, 75% (HPLC)
Sigma-Aldrich
Methylene Blue Solution 1.4%(w/v)95%ethanol | 7220-79-3, 1.4 % (w/v) in 95% ethanol
Sigma-Aldrich
Metanolo, suitable for NMR (reference standard)
Sigma-Aldrich
Formaldehyde-12C solution, 20% in H2O, 99.9 atom % 12C